Dr. Alan Tahsin Ghassan, MD

Dr. Ghassan practices at Henry Ford Semi Medical Group in Farmington Hills, Michigan.

Dr. Ghassan's NPI, 1760450811, was assigned on March 14, 2006. Dr. Ghassan holds Michigan license 4301081430.

Dr. Ghassan's primary practice is Henry Ford Semi Medical Group, at 24333 Orchard Lake Rd, Farmington Hills, MI 48336 in Oakland County. The practice phone is (248) 680-8000.

Dr. Ghassan's primary practice is Henry Ford Semi Medical Group in Farmington Hills, Michigan. Dr. Ghassan is also affiliated with Corewell Health Farmington Hills Hospital. The medical group on file is Park Family Practice (Infinity Primary Care, PLLC). Dmand AI also links Dr. Ghassan to 4 more hospitals, 1 physician office, 1 group practice or clinic, 1 therapy and rehab clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Ghassan practices, 8 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Ghassan's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Ghassan is licensed in Michigan.

CMS data shows 2,633 Medicare services from Dr. Ghassan across 18 procedure codes in 2024, for 393 Medicare patients. Medicare paid $196,896 for them.

CMS counts 393 Medicare patients who saw Dr. Ghassan in 2024. The largest group is 65 to 74, with 142 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 22% are also on Medicaid. Their average risk score is 1.94, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Ghassan's median patient age at 69, with 55% women.

In 2024, Dr. Ghassan wrote 9,489 Medicare Part D claims for 631 patients. 85% of them were for generic drugs. CMS names the drug for 8,811 of them, across 146 drugs with 11 or more claims each, at $831,285 in total drug cost. In 2023, CMS named 8,622 claims across 141 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Ghassan for performance year 2024, reported through an alternative payment model (APM). Dr. Ghassan accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 260 general payments to Dr. Ghassan from 23 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Pfizer Inc. paid the most, $1,137.